Fentanyl buccal - Generex Biotechnology
Alternative Names: Fentanyl citrate buccal - Generex; Fentanyl oral spray - GenerexLatest Information Update: 31 Dec 2021
At a glance
- Originator Generex Biotechnology Corporation
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Mar 2018 No recent reports of development identified for phase-I development in Pain in Canada (Buccal, Spray)
- 21 Mar 2016 This programme is still active
- 10 Jan 2013 Fentanyl buccal is available for licensing as of 10 Jan 2013. http://www.generex.com/